Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis D Kapoor, RC Guptan, SM Wakil, SN Kazim, R Kaul, SR Agarwal, ... Journal of hepatology 33 (2), 308-312, 2000 | 252 | 2000 |
Overexpression of hyaluronan-binding protein 1 (HABP1/p32/gC1qR) in HepG2 cells leads to increased hyaluronan synthesis and cell proliferation by up-regulation of cyclin D1 in … R Kaul, P Saha, M Saradhi, RLA Prasad, S Chatterjee, I Ghosh, RK Tyagi, ... Journal of Biological Chemistry 287 (23), 19750-19764, 2012 | 41 | 2012 |
Inhibition of Mucin-Type O-Glycosylation through Metabolic Processing and Incorporation of N-Thioglycolyl-d-galactosamine Peracetate (Ac5GalNTGc) K Agarwal, R Kaul, M Garg, A Shajahan, SK Jha, SG Sampathkumar Journal of the American Chemical Society 135 (38), 14189-14197, 2013 | 31 | 2013 |
Role of PXR in hepatic cancer: its influences on liver detoxification capacity and cancer progression D Kotiya, B Jaiswal, S Ghose, R Kaul, K Datta, RK Tyagi PLoS One 11 (10), e0164087, 2016 | 25 | 2016 |
Supplementation of pyrroloquinoline quinone with atorvastatin augments mitochondrial biogenesis and attenuates low grade inflammation in obese rats K Devasani, R Kaul, A Majumdar European Journal of Pharmacology 881, 173273, 2020 | 14 | 2020 |
Human gene encoding hyaluronan binding protein 1 (HABP1/p32/gC1qR): involvement in signaling cascade P Saha, R Kaul, K Datta The Nucleus 60, 221-226, 2017 | 1 | 2017 |
Effect of co-expression of alpha-synuclein and leucine-rich repeat kinase 2 on the hallmark features of Parkinson’s disease in Drosophila melanogaster D Jhonsa, K Devasani, R Kaul, M Saraf NIScPR-CSIR, India, 2023 | | 2023 |
Pyrroloquinoline Quinone inhibits PCSK9, augments LDLR recycling and enhances the effect of atorvastatin K Devasani, A Majumdar, D Jhonsa, R Kaul bioRxiv, 2022.03. 20.485060, 2022 | | 2022 |
Disrupting the sugar-coat: Inhibition of mucin-type O-glycosylation through metabolic glycan engineering S Sampathkumar, K Agarwal, R Kaul, M Garg, S Asif, SM Ahmed, SK Jha GLYCOBIOLOGY 22 (11), 1613-1614, 2012 | | 2012 |
9. Teaching and Research Experience of Principal Investigator K Basu, I Ghosh, R Kaul Signal 23 (10), 1563-77, 2011 | | 2011 |
Natural history of break through phenomenon during interferon therapy for chronic HCV infection. RKC Guptan, R Kaul, V Thakur, SK Sarin HEPATOLOGY 32 (4), 567A-567A, 2000 | | 2000 |
Functional analysis of the role of hyaluronan binding protein-1 (HABP1) in human liver cancer cell line R Kaul Delhi, 0 | | |